Therapy might emerge as an effective and safe treatment for patients with both MS and LD. clinical trials & follow-up studies are needed to prove the long-term efficacy of hESC therapy in the treatment of patients with MS and LD.
The purpose of this study was to evaluate the longitudinal changes in brain perfusion in patients with Lyme disease treated with human embryonic stem cells & MSC Stem Cell Capsules